Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics

被引：4
|
作者：
Sarah, Allegra [1 ,2 ]
Dondi, Emma [1 ]
De Francia, Silvia [1 ]
机构：
[1] Univ Turin, S Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Orbassano, TO, Italy
[2] Univ Turin, San Luigi Gonzaga Hosp, Dept Clin & Biol Sci, Clin Pharmacol Serv Franco Ghezzo, Reg Gonzole 10, I-10043 Turin, TO, Italy
来源：
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY | 2023年 / 19卷 / 11期
关键词：
Chemotherapy; Cancer; Precision Medicine; Personalized Treatment; IMATINIB;
D O I：
10.1080/17425255.2023.2277758
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：733 / 739
页数：7
相关论文
共 50 条
  • [1] Pharmacogenetics of small-molecule tyrosine kinase inhibitors: Optimizing the magic bullet
    Pander, Jan
    Guchelaar, Henk-Jan
    Gelderblom, Hans
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (06) : 654 - 661
  • [2] The Role of Organic Cation Transporters in the Pharmacokinetics, Pharmacodynamics and Drug-Drug Interactions of Tyrosine Kinase Inhibitors
    Xiu, Fangrui
    Rausch, Magdalena
    Gai, Zhibo
    Su, Shanshan
    Wang, Shijun
    Visentin, Michele
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [3] Progress in Research on Protein Tyrosine Kinase Inhibitors Progress in Research on Protein Tyrosine Kinase Inhibitors
    Chen, Yu
    INTERNATIONAL CONFERENCE ON FRONTIERS OF BIOLOGICAL SCIENCES AND ENGINEERING (FBSE 2018), 2019, 2058
  • [4] Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors: Implications for Therapeutic Drug Monitoring
    Josephs, Debra H.
    Fisher, Danielle S.
    Spicer, James
    Flanagan, Robert J.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 562 - 587
  • [5] PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics
    Zeng, Yi
    Arisa, Oluwatobi
    Peer, Cody J.
    Fojo, Antonio
    Figg, William D.
    SEMINARS IN ONCOLOGY, 2024, 51 (1-2) : 19 - 24
  • [6] Cardiotoxicity induced by tyrosine kinase inhibitors
    Orphanos, George S.
    Ioannidis, George N.
    Ardavanis, Alexandros G.
    ACTA ONCOLOGICA, 2009, 48 (07) : 964 - 970
  • [7] Tyrosine kinase inhibitors
    Hantraye, Benedicte
    Leroux, Amelie
    Clere, Nicolas
    ACTUALITES PHARMACEUTIQUES, 2015, 54 (551): : 22 - 27
  • [8] Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
    Michael S. Mathisen
    Susan O’Brien
    Deborah Thomas
    Jorge Cortes
    Hagop Kantarjian
    Farhad Ravandi
    Current Hematologic Malignancy Reports, 2011, 6
  • [9] Tyrosine kinase inhibitors and pregnancy: A risk to the fetus?
    Jovelet, Cecile
    Broutin, Sophie
    Gil, Sophie
    Mir, Olivier
    Paci, Angelo
    BULLETIN DU CANCER, 2016, 103 (05) : 478 - 483
  • [10] Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients
    Allegra, Sarah
    Dondi, Emma
    Chiara, Francesco
    De Francia, Silvia
    BIOMEDICINES, 2023, 11 (09)
12345